PANION & BF BIOTECH INC.

🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

Evaluate the Efficacy and Safety of Brightening Micro-needle Patch on Facial Solar Lentigines

First Posted Date
2020-10-12
Last Posted Date
2022-05-24
Lead Sponsor
Panion & BF Biotech Inc.
Target Recruit Count
35
Registration Number
NCT04583852
Locations
🇨🇳

Department of Dermatology, National Taiwan University, Taipei, Taiwan

PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD

First Posted Date
2020-09-10
Last Posted Date
2023-03-09
Lead Sponsor
Panion & BF Biotech Inc.
Target Recruit Count
141
Registration Number
NCT04543812
Locations
🇨🇳

Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan

🇨🇳

Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan

🇨🇳

Division of Nephrology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan

and more 5 locations

Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

First Posted Date
2019-06-13
Last Posted Date
2021-03-10
Lead Sponsor
Panion & BF Biotech Inc.
Target Recruit Count
240
Registration Number
NCT03984760
Locations
🇨🇳

Meihekou Central Hospital, Meihekou, China

🇨🇳

The Affiliated Hospital of Qingdao University, Qingdao, China

🇨🇳

Shengjing Hospital of China Medical University, Shenyang, China

and more 21 locations

Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis

First Posted Date
2017-08-22
Last Posted Date
2020-01-13
Lead Sponsor
Panion & BF Biotech Inc.
Target Recruit Count
202
Registration Number
NCT03256838
Locations
🇨🇳

Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

🇨🇳

Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan

🇨🇳

Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan

and more 6 locations

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease

First Posted Date
2012-01-04
Last Posted Date
2020-01-13
Lead Sponsor
Panion & BF Biotech Inc.
Target Recruit Count
183
Registration Number
NCT01503736
Locations
🇨🇳

Division of Nephrology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan

🇨🇳

Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang-Gung Memorial Hospital, Kaohsiung, Taiwan

🇨🇳

Division of Nephrology, Department of Internal Medicine, Far East Memorial Hospital, New Taipei City, Taiwan

and more 2 locations
© Copyright 2024. All Rights Reserved by MedPath